Institut für Experimentelle und Klinische Pharmakologie und Toxikologie


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Assessment of odor hedonic perception: the Sniffin’ sticks parosmia test (SSParoT) (2020) Liu DT, Welge-Lüssen A, Besser G, Mueller CA, Renner B Journal article Odor Mixtures in Identification Testing Using Sniffin’ Sticks: The SSomix Test (2020) Liu DT, Besser G, Lang M, Sharma G, Pablik E, Renner B, Mueller CA Journal article Radiological Markers of the Olfactory Cleft: Relations to Unilateral Orthonasal and Retronasal Olfactory Function (2020) Liu DT, Schwarz-Nemec U, Renner B, Mueller CA, Besser G Journal article Brain fMRI Predicts Responses to Certolizumab Pegol in RA. an International, Multi-center, Randomized, Double-blind, Placebocontrolled Trial (PreCePRA) (2020) Rech J, Schenker H, Tascilar K, Hagen M, Kleyer A, Simon D, Mendez LV, et al. Conference contribution Editorial: Status Go for Preclinical Imaging (2020) Kuntner C, Baumann B, Tavares AAS, Heß A Journal article Prostaglandin E2 stimulates the epithelial sodium channel (ENaC) in cultured mouse cortical collecting duct cells in an autocrine manner (2020) Mansley M, Niklas C, Nacken R, Mandery K, Gläser H, Fromm M, Korbmacher C, Bertog M Journal article Vectorial transport of the arginine derivatives asymmetric dimethylarginine (ADMA) andl-homoarginine by OATP4C1 and P-glycoprotein studied in double-transfected MDCK cells (2020) Taghikhani EP, Maas R, Taudte V, Geßner A, Fromm M, König J Journal article The hyperpolarization-activated cyclic nucleotide-gated 4 channel as a potential anti-seizure drug target (2020) Kharouf Q, Phillips AM, Bleakley LE, Morrisroe E, Oyrer J, Jia L, Ludwig A, et al. Journal article CENTRAL NERVOUS SYSTEM PAIN RESPONSE AND COMPONENTS OF DISEASE ACTIVITY IN RA PATIENTS AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO: A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020) Schenker H, Rech J, Tascilar K, Hagen M, Schoenau V, Sergeeva M, Selvakumar M, et al. Conference contribution PREDICTION OF RESPONSE TO CERTOLIZUMAB PEGOL TREATMENT BY FUNCTIONAL MRI OF THE BRAIN: AN INTERNATIONAL, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (PRECEPRA) (2020) Rech J, Tascilar K, Schenker H, Sergeeva M, Selvakumar M, Konerth L, Prade J, et al. Conference contribution